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Abstract
Objective: The metabolic syndrome is a major public health challenge and identifies persons at risk for diabetes and
cardiovascular disease. The aim of this study was to examine the association between age at menarche and the metabolic
syndrome (IDF and NCEP ATP III classification) and its components.
Design: 1536 women aged 32 to 81 years of the German population based KORA F4 study were investigated. Data was
collected by standardized interviews, physical examinations, and whole blood and serum measurements.
Results: Young age at menarche was significantly associated with elevated body mass index (BMI), greater waist
circumference, higher fasting glucose levels, and 2 hour glucose (oral glucose tolerance test), even after adjusting for the
difference between current BMI and BMI at age 25. The significant effect on elevated triglycerides and systolic blood
pressure was attenuated after adjustment for the BMI change. Age at menarche was inversely associated with the metabolic
syndrome adjusting for age (p-values: ,0.001 IDF, 0.003 NCEP classification) and additional potential confounders including
lifestyle and reproductive history factors (p-values: 0.001, 0.005). Associations remain significant when additionally
controlling for recollected BMI at age 25 (p-values: 0.008, 0.033) or the BMI change since age 25 (p-values: 0.005, 0.022).
Conclusion: Young age at menarche might play a role in the development of the metabolic syndrome. This association is
only partially mediated by weight gain and increased BMI. A history of early menarche may help to identify women at risk
for the metabolic syndrome.
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Introduction
Menarche, the onset of menstruation in girls, indicates the
attainment of reproductive capacity. Age at menarche is inversely
associated with adiposity in childhood and adulthood [1–5], risk
for cardiovascular morbidity and mortality [6,7] as well as type 2
diabetes mellitus [8,9]. Efforts to identify women at risk of these
diseases earlier in life are very important in order to enable benefit
from preventive interventions. Fulfilling the criteria of the
metabolic syndrome, a clustering of metabolic risk factors,
increases the risk of developing cardiovascular disease and
diabetes. The metabolic syndrome has become one of the major
public health challenges worldwide [10]. For example, among
women in Southern Germany, aged 55 to 74 years, 24 and 46%
were categorized as having the metabolic syndrome based on the
2005 National Cholesterol Education Program, Adult Treatment
Panel III (NCEP ATP III) and the 2005 International Diabetes
Federation (IDF) criteria, respectively [11]. The metabolic
syndrome, its single components and its clustering are markers
for high health care utilization and high costs among patients
receiving medical care [12].
There are different classifications of the metabolic syndrome
leading to confusion and an incomparability of studies [10].
However, all definitions are to some degree suitable for the early
detection of type 2 diabetes or cardiovascular diseases [13,14].
Boronat et al. showed that the IDF definition identifies a surplus of
individuals whose cardiovascular risk profile, particularly regard-
ing some non-traditional cardiovascular risk factors, is less adverse
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III definition [15].
Few studies have been conducted to examine the association
between age at menarche and risk of metabolic syndrome and the
findings have been inconclusive [16–19]. In addition, most of the
published studies on this issue have been conducted in Asian
populations, while studies based on European women are still
missing.
The aim of this study was to determine whether age at
menarche is independently associated with the metabolic syn-
drome, or whether it is triggered by body mass index (BMI) and
other factors. To be better able to compare the results with other
studies, we used two main classifications for the metabolic
syndrome, the IDF and NCEP ATP III classifications.
Methods
Subjects
The KORA F4 study is a follow-up study of the KORA S4
study, a ‘‘population-based’’ health survey conducted in the city of
Augsburg and two surrounding counties between 1999 and 2001.
A total sample of 6640 subjects was drawn from the target
population consisting of all German residents of the region aged 25
to 74 years. The study design, sampling method and data
collection have been described in detail elsewhere [20].
Of all 4261 participants of the S4 baseline study, 3080 also
participated in the 7-year follow-up F4 study. Persons were
considered ineligible for F4 if they had died in the meantime
(n=176, 4%), lived outside the study region, were lost to follow-up
(n=206, 5%), or had demanded deletion of their address data
(n=12, 0.2%). Of the remaining 3867 eligible persons, 174 could
not be contacted, 218 were unable to participate in the study
because they were too ill or had no time, and 395 were not willing
to participate in this follow-up, resulting in a response rate of
79.6%. The current study was restricted to 1594 female subjects,
aged 32 to 81 years at follow-up.
We excluded all women for whom no or only incomplete
information of age at menarche (n=35), status of metabolic
syndrome (NCEP ATP III and IDF classification) (n=14) and any
of the covariables was available (n=9). The final analysis therefore
included 1536 study participants, after excluding 2 probands due
to age at menarche, as described below.
Ethics Statement
All study participants gave written informed consent and the
study was approved by the Ethics Committee of the Bavarian
Medical Association.
Data Collection
Information on sociodemographic variables, physical activity
level, medication use, alcohol consumption, smoking habits and
reproductive history was obtained by trained medical staff during
a standardized face-to-face interview. In addition, all study
participants underwent a standardized medical examination that
included the collection of fasting venous blood samples and the
performance of an oral glucose tolerance test (oGTT) in all
subjects without previously known diabetes. All measurement
procedures are described in detail elsewhere [20]. Anthropometric
measurements were taken after the participants had removed their
shoes, heavy clothing and belts. Body height was measured to the
nearest 0.1 cm and weight to the nearest 0.1 kg. BMI was
calculated as weight [kg] divided by height
2 [m
2]. Waist
circumference (WC) was measured at the level midway between
the lower rib margin and the iliac crest. Recollected BMI was
calculated as weight at age 25 years, assessed in the standardized
interview [kg] divided by current height
2 [m
2] Actual hypertension
was defined as use of antihypertensive medication, being aware of
having hypertension or blood pressure values greater than 140/
90 mmHg. Participants who were engaged more than one hour
per week in physical activity in summer or winter were defined as
physically active. Known diabetes mellitus was defined as use of
antidiabetic medication or self-report which was validated by
questioning the treating physician.
Clinical chemical measurements
A fasting (at least 8 hours) venous blood sample was obtained
from all study participants while sitting. Blood glucose was
analyzed using a hexokinase method (GLU Flex of Dade Behring,
Germany).
Analyses for high-density lipoprotein (HDL) cholesterol were
carried out with AHDL Flex of Dade Behring, and fasting
triglycerides (TG) were measured with the TGL Flex GPO-PAP
assay of Dade Behring.
All additional analyses were carried out using the analyzer
Dimension RxL (Dade Behring, Germany).
Assessment of age at menarche
Age at menarche was defined as age at the first menstrual
bleeding, assessed in full years. This information was obtained by a
personal interview in the KORA S4 survey. The question was
open-ended: ‘‘At what age did you have your first menstrual
period (menarche)?’’ We excluded participants with menarche
after 18 years (n=2), because this may likely be due to a
pathological status or a recall error. For analysis, age at menarche
was categorized into three categories (,12 years, 12–15 years and
.15 years).
Classification of the metabolic syndrome
All subjects were classified whether or not they have the
metabolic syndrome according to the current IDF as well as
NCEP ATP III criteria. The IDF definition consists for European
women of central obesity ($80 cm WC), plus two of the following
symptoms: raised fasting TG (.150 mg/dl or drug treatment for
high TG), reduced HDL-cholesterol (,50 mg/dl or drug
treatment for this lipid abnormality), raised blood pressure
($130/85 mmHg or treatment for previously diagnosed hyper-
tension) and raised fasting plasma glucose ($100 mg/dl or
previously diagnosed type two diabetes) [10]. The NCEP ATP
III metabolic syndrome classification for women requires fulfill-
ment of at least three of the following criteria: raised fasting plasma
glucose ($100 mg/dl or previously diagnosed type two diabetes),
reduced HDL-cholesterol (,50 mg/dl or drug treatment for low
HDL-cholesterol), elevated fasting TG (.150 mg/dl or drug
treatment for high TG), raised blood pressure ($130/85 mmHg
or treatment for previously diagnosed hypertension) or central
obesity (WC$88 cm) [21].
Statistical analyses
Basic characteristics of the study population were analyzed
stratified by age at menarche (,12 years, 12–15 years and .15
years). For normally distributed variables the mean and standard
deviation, for non-normally distributed variables the median and
the interquartile range and for categorized variables the
percentages were calculated. The p-values are shown for the
difference of these variables between the three categories.
Linear regression analyses were fitted with age at menarche
supplied both as a categorized variable and in separate analyses as
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dependent variables. Age at menarche between 12 and 15 years
was the reference group in the categorized model. Results are
presented as least square means (lsmean) with 95% confidence
intervals (95% CI).
Fasting TG, HDL, FG and glucose 2 hours after oGTT (2-h
glucose) were not normally distributed. Thus, the log-transformed
normally distributed variables were used in all analyses. The
results are shown as the geometric means after back-transforma-
tion.
For the regression analyses several models were fitted,
controlling for the following potentially confounding variables.
Sociodemographic variables: age (years), education level (8–10,
11–12, 13–17 years), marital status (single, married, divorced or
widowed); lifestyle variables: current smoking (yes/no), alcohol
intake $20 g/day (yes/no) and physical activity regularly more
than one hour per week (yes/no); reproductive confounding
variables: parity (no pregnancy, 1–2, $3 pregnancies), current or
ever use of hormone replacement therapy (yes/no), current or ever
use of oral or other systemic functioning contraceptives (yes/no);
medical confounders: BMI (kg/m
2), WC (cm), recollected BMI at
age 25 (kg/m
2), BMI change since age 25 (kg/m
2), HDL-
cholesterol (mg/dl), TG (mg/dl), systolic and diastolic blood
pressure (mmHg), actual hypertension (yes/no), fasting glucose
(FG) and 2–hour glucose (mg/dl) if an oGTT has been conducted.
Trend tests were performed by using age at menarche as a linear
variable.
Additionally, a test of interaction has been conducted for age at
examination with age at menarche (in years) for all analyzed
variables. The tests showed no statistically significant interaction
(all p-values$0.05).
Logistic regression models were performed to test the
association between categorized age at menarche and the
metabolic syndrome (both definitions). Confounder adjustment
was done as described for the linear regression models.
Significance tests were two-tailed and p-values less than 0.05
were considered statistically significant. All analyses were per-
formed using SAS (version 9.1, SAS Institute Inc, Cary, NC,
USA).
Results
The mean age at menarche in our study sample was 13.5 years,
with a standard deviation of 1.6. The mean age of the study
participants was 55.6 years with a standard deviation of 13.1. The
sample characteristics by age at menarche are provided in Table 1.
Age at time of survey shows the strongest relationship with age at
menarche. In summary, women reporting an age at menarche
below 12 years had a lower current age, a higher mean BMI, a
greater WC and a higher recollected BMI at age 25 years, were
more likely to be a current smoker and less physically active than
women with an age at menarche between 12 and 15 years.
Furthermore, women with an age at menarche below 12 years
more often suffered from diabetes mellitus, had higher mean TG,
lower mean HDL-cholesterol and higher FG levels in comparison
to women with an age at menarche between 12 and 15 years.
Women with an age at menarche above 15 years were older, less
likely to smoke, more likely to be physically active and to be
divorced than women with an age at menarche between 12 and 15
years. In addition, they had less often ever used oral contraceptives
and were more likely to have actual hypertension.
The association between age at menarche in three categories
and single components of the metabolic syndrome and cardiovas-
cular risk factors is shown in Table 2 and in Table S1. Additional
analysis of age at menarche as linear variable confirmed the results
of the analyses with the categorized variable. Both analyses
showed an inverse association between age at menarche and BMI,
WC, FG and 2-h glucose. The relationship with systolic blood
pressure and TG was attenuated after adjustment for recollected
BMI at age 25 or the BMI change since age 25 years. There was
no statistically significant association between age at menarche and
HDL cholesterol levels as well as diastolic blood pressure.
Age at menarche showed no association with education level,
marital status, current use of hormone replacement or oral
contraceptive use and these variables were therefore not included
in the models.
There were 421 cases with the metabolic syndrome using the
IDF and 383 cases using the NCEP ATP III classification.
Early age at menarche was significantly associated with the
metabolic syndrome after controlling for age (p-values for trend
with age at menarche as continuous variable: ,0.001 IDF, 0.003
NCEP ATP III) (Table 3). Adjustment for age, physical activity,
smoking habits, alcohol consumption, parity, ever use of oral
contraceptives or ever use of hormone replacement therapy
showed practically unchanged p-values. A model including
recollected BMI at age 25 years to the lifestyle and reproductive
adjusted model showed a weaker association with p-values of
0.008 and 0.033. The model with adjustement for the BMI change
since age 25 years in addition to all other confounding factors is
comparable to the results of the model with all confounders
additionally to the recollected BMI at age 25 years (p-values: 0.005
IDF, 0.022 NCEP) (Table 3). Later age at menarche showed no
significant associations with the metabolic syndrome in compar-
ison to the age at menarche from 12 to 15 years, but a trend
towards lower odds ratios was seen.
Discussion
This study shows that low age at menarche is associated with a
higher risk of having the metabolic syndrome and most of its single
components in women aged 32 to 81 years, even after controlling
for potential confounders (age, lifestyle factors, reproductive
history, recollected BMI at age 25 years, and BMI change since
age 25 years). Early onset of menarche in comparison to the group
age at menarche between 12 and 15 years was associated with the
metabolic syndrome defined according to the NCEP ATP III and
the IDF classification. Later age at menarche showed no
significant association but a trend towards lower odds ratios was
seen. The results are quite similar for the two different definitions
of the metabolic syndrome.
Our study is in good agreement with previous studies (1–5)
showing that age at menarche is inversely associated with body
mass index and waist circumference.
Results of other studies on the metabolic syndrome and
its components
Studies on the association between age at menarche and
metabolic syndrome are sparse and present contradictory results
[16–19].
A study of 892 postmenopausal women who participated in the
2005 Korean National Health and Nutrition Survey showed no
association between age at menarche and metabolic syndrome
[16]. The Bogalusa Heart Study conducted among 1479 young
adult women (19–37 years), found that early menarche is
characterized by a higher prevalence of clustered risk variables,
which are part of the metabolic syndrome. Unfortunately, this
study did not examine the effect directly on the metabolic
syndrome [18]. A further study including 7349 Chinese women
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for the metabolic syndrome in women with an age at menarche
below 12.5 years, using the NCEP ATP III classification [19]. A
study of 9000 Chinese women aged 25 to 64 years reported that
age at menarche was inversely associated with the total number of
metabolic syndrome components and the metabolic syndrome
using the IDF classification [17].
A previous literature review, published in 1999 on reproductive
history and cardiovascular disease risk in postmenopausal women
showed no association between age at menarche and cardiovas-
cular risk factors [22]. However, recent publications don’t support
this result. The Epic Norfolk cohort study showed in 15,807
participants that age at menarche below 12 years is associated with
incident cardiovascular disease (1.17; 1.07–1.27), incident coro-
nary heart disease (1.23; 1.06–1.62) and a higher risk of
hypertension (1.13; 1.02–1.24). These associations were only
partly mediated by adiposity [6]. Additionally, a study of 794
Finnish women found that early menarche is only a risk marker,
and that greater childhood BMI contributes to the earlier age at
menarche and hence increases adult BMI and subsequently
cardiovascular risk [7]. On the contrary, a Japanese cohort study
with 37,965 postmenopausal women aged 40–79 years showed no
association between age at menarche and mortality of coronary
heart disease [23]. In our study, we examined the association of
Table 1. Sample characteristics, by age at menarche.
Age at menarche (years) ,12 12–15 .15
n=121 n=1257 n=158
% Mean SD % Mean SD % Mean SD p-value
Age at time of the survey (years) 53.1 12.0 55.1 12.9 61.5 13.1 ,0.001
Body mass index (kg/m
2) 28.2 5.6 27.3 5.3 27.0 5.0 0.136
Waist circumference (cm) 89.7 13.9 88.0 13.3 87.8 12.7 0.369
Recalled BMI at age 25 (kg/m
2) 23.4 4.4 22.3 3.3 22.4 3.4 0.004
HDL- cholesterin
2 (mg/dl) 58.4 13.1 61.6 14.4 61.0 13.9 0.063
Fasting triglycerides
2 (mg/dl) 123.4 88.0 105.1 64.6 114.9 62.6 0.005
Alcohol consumption (.20 g/day) 19.8 15.1 10.8 0.231
Current smoker (%) 19.8 15.4 12.7 0.257
Systolic blood pressure (mmHg) 117.7 17.6 116.9 18.0 117.7 18.9 0.809
Diastolic blood pressure (mmHg) 74.0 8.9 72.8 9.3 72.5 10.2 0.388
Diabetes mellitus (%) 9.1 5.5 7.6 0.187
Actual hypertension
3 (%) 33.9 32.5 38.6 0.248
Physically active (more than one hour per week) (%) 41.3 56.6 58.9 0.004
Pregnancies (%) 0.205
0 pregnancies 17.4 14.2 17.7
1–2 pregnancies 48.8 50.0 40.5
$3 pregnancies 33.9 35.9 41.8
Education (years) (%) 0.128
8–10 47.1 48.3 58.2
11–12 25.6 22.9 21.5
13–17 27.3 28.8 20.3
Marital status (%) 0.149
Single 14.0 9.1 9.5
Married 70.2 69.8 64.9
Divorced or widowed 15.7 21.1 25.9
Current use of systemic hormone replacement therapy (%) 9.9 8.7 10.8 0.653
Ever use of systemic hormone replacement therapy (%) 32.2 29.4 31.6 0.699
Current use of oral/systemic contraceptives (%) 8.3 6.1 7.0 0.623
Ever use of oral/systemic contraceptives (%) 74.4 74.8 65.8 0.054
Fasting glucose
2 (mg/dl) 97.6 21.4 94.0 14.9 96.0 17.9 0.029
2-h glucose
2 (mg/dl) 105.0 43.0 103.0 39.0 104.0 40.0 0.296
HbA1c (%) 5.5 0.5 5.5 0.5 5.6 0.6 0.016
Abbreviation: SD: Standard deviation.
p-value, testing the difference between the 3 categories of age at menarche.
2the median and the interquartile range are given due to a non-normal distribution of these variables.
3defined as use of antihypertensive medication, being aware of having hypertension or blood pressure values greater than 140/90 mmHg.
doi:10.1371/journal.pone.0026076.t001
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the metabolic syndrome, which represent selected cardiovascular
risk factors, e.g. systolic blood pressure or TG which showed a
significant association before adjustment for the BMI at age 25 or
the BMI change since.
Gunderson et al. reported that childbearing is associated with
higher incidence of the metabolic syndrome among women of
reproductive age controlling for measurements of the components
of the metabolic syndrome before pregnancy [24]. A study with
Chinese women confirmed these results [25]. Other studies
showed that this effect is a combination of lifestyle risk factors
and/or biological changes associated with childbearing, which
may explain the positive association between parity and increased
risk of metabolic syndrome [16,26]. In contrast to these studies,
Cho et.al. found, that age at first birth was negatively associated
with the metabolic syndrome, but not parity in 892 postmeno-
Table 2. Age at menarche and its association with selected cardiovascular risk factors and components of the metabolic
syndrome.
Age at menarche ,12 12–15 .15
(years) n=121 n=1257 n=158
lsmean CI lsmean CI lsmean CI p-value for trend*
BMI (kg/m
2)
Age-adjusted 28.5 27.6 29.4 27.3 27.0 27.6 26.3 25.5 27.1 ,0.001
Complete model 27.9 27.0 28.8 26.9 26.4 27.4 25.9 25.0 26.8 ,0.001
Complete+BMI 28.2 27.6 28.9 27.2 26.9 27.5 27.1 26.5 27.7 ,0.001
Waist circumference (cm)
Age-adjusted 90.6 88.4 92.8 88.2 87.5 88.9 85.5 83.6 87.5 ,0.001
Complete model 89.8 87.5 92.1 87.8 86.7 89.0 85.3 83.2 87.5 ,0.001
Complete+BMI 90.6 88.9 92.3 88.6 87.7 89.3 88.1 86.5 89.7 0.002
Systolic blood pressure (mmHg)
Age-adjusted 119.1 116.2 122.1 117.2 116.3 118.1 114.4 111.8 117.0 0.017
Complete model 118.3 115.1 121.4 116.6 115.1 118.2 113.9 111.0 116.8 0.026
Complete+BMI 118.3 115.2 121.4 116.5 115.0 118.0 114.6 111.7 117.5 0.049
Diastolic blood pressure (mmHg)
Age-adjusted 74.1 72.4 75.7 72.9 72.3 73.4 72.3 70.8 73.8 0.268
Complete model 73.6 71.8 75.4 72.5 71.6 73.3 72.0 70.3 73.6 0.321
Complete+BMI 73.7 71.9 75.4 72.5 71.7 73.4 72.5 70.8 74.1 0.485
Fasting triglycerides (mg/dl)
Age-adjusted 107.7 98.8 117.4 92.3 89.9 94.8 92.8 86.0 100.1 0.015
Complete model 107.5 98.1 117.7 93.1 89.1 97.4 93.9 86.3 102.2 0.021
Complete+BMI 108.8 99.7 118.7 94.3 90.3 98.4 97.6 89.9 105.9 0.060
HDL cholesterol (mg/dl)
Age-adjusted 57.0 54.6 59.4 59.9 59.2 60.7 59.5 57.4 61.8 0.123
Complete model 57.1 54.7 59.6 59.6 58.3 60.9 59.1 56.8 61.5 0.152
Complete+BMI 56.6 54.4 59.0 59.1 58.0 60.3 57.8 55.6 60.1 0.351
Fasting glucose (mg/dl)
Age-adjusted 96.9 94.7 99.3 93.3 92.6 93.9 92.4 90.5 94.3 ,0.001
Complete model 96.5 94.1 98.9 93.0 91.9 94.2 92.1 90.0 94.3 ,0.001
Complete+BMI 96.7 94.5 99.0 93.4 92.3 94.5 93.6 91.5 95.6 0.003
2-h glucose** (mg/dl)
Age-adjusted 110.6 104.8 116.7 104.9 103.2 106.6 101.9 97.1 106.9 0.003
Complete model 108.9 102.9 115.2 103.7 100.9 106.6 100.7 95.5 106.1 0.004
Complete+BMI 109.6 103.9 115.7 104.3 101.6 107.1 102.8 97.6 108.2 0.009
Abbreviations: CI: Confidence Interval, BMI: Body mass index, HDL: High density lipoprotein, lsmean: least square means.
*the p-values for trend are reported for age at menarche as continuous variable.
**2-h glucose: glucose 2 hours after an oral glucose challenge; n=1417 due to the non-performance of the oGTT in people with diagnosed diabetes.
Model 1: results were adjusted for age (in years).
Model 2: ‘‘complete model’’ results were adjusted for age (in years), number of pregnancies (no pregnancy, 1–2 pregnancies, more than 2 pregnancies), ever use of oral
contraceptives, ever use of hormone replacement therapy, physical activity (less and more than one hour per week), smoking habits (current or no current smoking) and
alcohol intake (more than 20 g per day).
Model 3: ‘‘complete plus BMI change’’ results were adjusted for all variables in model 2 plus the BMI change since age 25 years.
doi:10.1371/journal.pone.0026076.t002
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and the presence of the metabolic syndrome, which is probably
due to lack of power in our study.
The role of menarche in the development of the metabolic
syndrome is not yet clear. It is possible that early menarche only
presents a marker for childhood obesity. Whether it acts
additionally or as a risk factor by itself or through sex hormone
differences over the life span needs to be assessed. Existing data
suggest that about half of the variance in the timing of menarche is
due to genetic factors [27], and there seems to be a genetic basis
for the phenotypic associations between age at menarche and BMI
[28,29]. In addition, it was found that obesity in childhood is
associated with metabolic syndrome in adolescence and adulthood
[7,30]. The importance of targeting girls for anti obesity
interventions has therefore been emphasized [5,31]. Large
prospective studies are needed to understand the underlying
mechanisms by which menarche increases the risk for metabolic
syndrome and risk factors for cardiovascular diseases in adulthood.
Strengths and limitations
The strength of the current study is its representativeness since
results are based on a large sample, drawn from the general
population. Another strong point is the availability of data on lifestyle,
reproductive history and multiple cardiovascular risk factors,
measured according to a standardized protocol. Compared to other
studies, weight and height data are based on measurements rather
than self-reported data, which reduces biases as participants tend to
under-report weight and over-report height [32]. Another great
advantage is the wide age-range in our study (between 32 and 81
years) since other studies only show results either for postmenopausal
female subjects or for subjects in younger adulthood.
Several limitations should be mentioned. Misclassification of age
at menarche might have happened due to the retrospective
assessment of this variable. However, studies have shown that the
actual reported mean age at menarche did not differ from the
mean age at menarche recalled 33 years later [33,34]. In addition,
misclassification of age at menarche is not likely to be associated
with the metabolic syndrome. This study unfortunately could not
adjust for premenarcheal BMI, which we replaced with the
variable recollected body weight at age 25. It is not possible to
obtain information on childhood BMI for our population based
sample of women, because registers or child health care centers
where this data could be recorded don’t exist in Germany. It has
been shown that the BMI in the twenties is strongly correlated with
the BMI in the youth and in the teenage years [35]. Nevertheless,
recalls of BMI at age 25 are still subject to recall biases and don’t
rule out additional confounding. Misclassification of other
variables needs to be considered since some of the covariables
were measured by self reports of the subjects, like alcohol
consumption, smoking habits and physical activity. A further
limitation of this study is that it has a cross-sectional design,
implicating that cause and effect relationships cannot be discerned.
Table 3. Odds ratios for metabolic syndrome (IDF and NCEP ATP III Classification) according to age at menarche.
Age at menarche ,12 12–15 .15
(years) (reference)
OR CI OR OR CI
p-value for
trend*
Classification IDF
Number of cases: 421
Model 1 1.65 1.07 2.55 1.00 0.79 0.54 1.17 ,0.001
Model 2 1.54 0.99 2.38 1.00 0.80 0.54 1.20 0.001
Model 3 1.66 1.07 2.56 1.00 0.79 0.53 1.17 ,0.001
Model 4 1.55 1.00 2.42 1.00 0.80 0.53 1.19 0.001
Model 5 1.43 0.91 2.25 1.00 0.79 0.52 1.20 0.008
Model 6 1.70 1.06 2.72 1.00 0.97 0.62 1.51 0.005
Classification NCEP ATP III 2005
Number of cases: 383
Model 1 1.69 1.08 2.64 1.00 0.83 0.56 1.24 0.003
Model 2 1.57 1.00 2.47 1.00 0.84 0.56 1.27 0.006
Model 3 1.69 1.08 2.65 1.00 0.83 0.56 1.24 0.003
Model 4 1.58 1.00 2.49 1.00 0.84 0.56 1.26 0.005
Model 5 1.45 0.91 2.30 1.00 0.86 0.56 1.31 0.033
Model 6 1.79 1.09 2.92 1.00 1.08 0.68 1.71 0.022
*p-values for trend with age at menarche as linear variable.
Abbreviations: OR: odds ratio, CI: confidence interval.
Model 1: results were adjusted for age (in years).
Model 2: ‘‘Life-style model’’: results were adjusted for age (in years), physical activity (less or more than one hour per week), current smoking (yes/no) and alcohol intake
(less or equal and more than 20 g per day).
Model 3: ‘‘reproductive model’’: results were adjusted for age (in years), number of pregnancies (no pregnancy, 1–2 pregnancies, more than 2 pregnancies), ever use of
oral contraceptives and ever use of hormone replacement therapy.
Model 4: ‘‘complete model’’: results were adjusted for all above mentioned factors (model 2 and 3).
Model 5: results were adjusted for all the variables in model 4 plus recollected BMI at age 25 years.
Model 6: results were adjusted for all the variables in model 4 plus the BMI change since age 25 years.
doi:10.1371/journal.pone.0026076.t003
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In conclusion, the present study showed that an earlier age at
menarche plays a role in the development of the metabolic syndrome.
This association is only partially mediated by weight gain and
increased BMI. A history of early menarche, especially before the age
of 12 years, may help to identify women at risk for the metabolic
syndrome and an increased body mass index. Early identification of
women at risk may help to prevent metabolic syndrome and the
subsequent development of cardiovascular diseases and diabetes.
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